Literature DB >> 8226839

Deconjugation of bilirubin-IX alpha glucuronides: a physiologic role of hepatic microsomal beta-glucuronidase.

J F Whiting1, J P Narciso, V Chapman, B J Ransil, R T Swank, J L Gollan.   

Abstract

beta-Glucuronidase is an acid hydrolase located in both the lysosomal and microsomal compartments of the hepatocyte. The function of the latter remains undefined. We postulated that microsomal beta-glucuronidase may be responsible for the deconjugation of bilirubin-IX alpha glucuronides which are synthesized primarily in the hepatic microsomal compartment. We utilized two unique congenic strains of mice to characterize the role of hepatic beta-glucuronidase in the metabolism and disposition of bilirubin-IX alpha; the first exhibited less than 1% of total hepatic beta-glucuronidase activity (ATM), the second lacked only the microsomal enzyme activity (AT1). The biliary excretion of bilirubin-IX alpha conjugates was quantitated using reverse-phase high performance liquid chromatography. Under basal conditions, there was a 2-fold increase in the biliary excretion of bilirubin-IX alpha monoglucuronides and total glucuronides in the AT1 and ATM mutants compared to the normal controls. When the plasma bilirubin-IX alpha level was increased to approximately 7 mg/dl to simulate hyperbilirubinemia, by intravenous administration of [14C]bilirubin-IX alpha, mathematical modeling of the biliary excretion curves of bilirubin-IX alpha glucuronides revealed qualitative differences between control and mutant animals, whereas both mutant groups were similar. Collectively, these data demonstrate that microsomal beta-glucuronidase modulates the net rate of bilirubin-IX alpha glucuronidation and glucuronide excretion in bile, under both basal and hyperbilirubinemic conditions, and that lysosomal beta-glucuronidase has no such effects. Hepatic microsomal beta-glucuronidase appears likely to influence the biliary excretion and hence the hepatic elimination of endogenous and xenobiotic substrates (e.g. carcinogens) which undergo hepatic glucuronidation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226839

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.

Authors:  Chunying Gao; Michael Z Liao; Lyrialle W Han; Kenneth E Thummel; Qingcheng Mao
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

Review 3.  New pathophysiological concepts underlying pathogenesis of pigment gallstones.

Authors:  Libor Vítek; Martin C Carey
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-10-05       Impact factor: 2.947

Review 4.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 5.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Dietary and demographic correlates of serum beta-glucuronidase activity.

Authors:  Sonia S Maruti; Lin Li; Jyh-Lurn Chang; Joann Prunty; Yvonne Schwarz; Shuying S Li; Irena B King; John D Potter; Johanna W Lampe
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

7.  Esterase 22 and beta-glucuronidase hydrolyze retinoids in mouse liver.

Authors:  Renate Schreiber; Ulrike Taschler; Heimo Wolinski; Andrea Seper; Stefanie N Tamegger; Maria Graf; Sepp D Kohlwein; Guenter Haemmerle; Robert Zimmermann; Rudolf Zechner; Achim Lass
Journal:  J Lipid Res       Date:  2009-08-31       Impact factor: 5.922

8.  A product of heme catabolism modulates bacterial function and survival.

Authors:  Christopher L Nobles; Sabrina I Green; Anthony W Maresso
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.